Autologous Fat Grafting to the Breast
Recruitment status was Recruiting
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
Purpose
Structural fat grafting is a form of tissue transfer where the autologous fat is harvested and subsequently transferred to a different region of the body at the same setting. It is an excellent technique for filling soft tissue and contour defects. Fat has the benefit of being abundantly available and easy to harvest. Further more, it is cheap and autogenous and thus lacks the side effects of synthetic fillers or implants. Autogenous fat transfer is a relatively common procedure performed by plastic and reconstructive surgeons. The goal of fat grafting is to provide the patient with a predictable, long lasting autogenous soft tissue augmentation. Autogenous fat transfer has been used extensively as an adjunct to facial rejuvenation. As well it has been applied to body contouring and augmentation of the hips, trochanteric areas, thighs and buttocks, back, torso and breast. The transfer of autologous fat dates back to 1890s and more specifically as injectable grafts since the 1920s. However, over the past 20 years the popularity of structural fat grafting has increased as a contouring modality. Fat transfer to the breast, popularized by Coleman, has been performed internationally since the 1990s. Despite the duration, the literature lacks accurate outcomes data on fat transfer to the breast and questions regarding the viability of adipocytes after the transfer exist. Sources from various publications show cell viability of up to 100% however studies of long term clinical outcomes quote rates of 10% to 80%.
| Condition | Intervention |
|---|---|
|
Micromastia Breast Ptosis Implant Failure Breast Reconstruction Congenital Malformations |
Procedure: Autologous Fat Grafting to Breasts |
| Study Type: | Interventional |
| Study Design: | Endpoint Classification: Efficacy Study Intervention Model: Single Group Assignment Masking: Open Label Primary Purpose: Treatment |
| Official Title: | Autologous Fat Grafting to the Breast |
- 3 Dimensional volumetric analysis of results and photographic analysis by board certified plastic surgeons. [ Time Frame: 3 months, 6 months and annually ] [ Designated as safety issue: Yes ]
- Patient satisfaction with cosmetic and reconstructive results [ Time Frame: 3 months, 6 months and annually ] [ Designated as safety issue: Yes ]
| Estimated Enrollment: | 50 |
| Study Start Date: | June 2008 |
| Estimated Study Completion Date: | June 2010 |
| Estimated Primary Completion Date: | June 2010 (Final data collection date for primary outcome measure) |
| Arms | Assigned Interventions |
|---|---|
| Experimental: Implant Failure |
Procedure: Autologous Fat Grafting to Breasts
Fat injection of Fat to breasts
Other Names:
|
| Experimental: Post mastectomy breast reconstruction |
Procedure: Autologous Fat Grafting to Breasts
Fat injection of Fat to breasts
Other Names:
|
| Experimental: Congenital malformations |
Procedure: Autologous Fat Grafting to Breasts
Fat injection of Fat to breasts
Other Names:
|
| Experimental: Breast Ptosis |
Procedure: Autologous Fat Grafting to Breasts
Fat injection of Fat to breasts
Other Names:
|
| Experimental: Micromastia |
Procedure: Autologous Fat Grafting to Breasts
Fat injection of Fat to breasts
Other Names:
|
| Experimental: Asymmetric Breasts |
Procedure: Autologous Fat Grafting to Breasts
Fat injection of Fat to breasts
Other Names:
|
Detailed Description:
Our goal with this study is to prospectively acquire information with our protocol that will outline the accurate long-term outcomes of fat transfer to the breast. Currently, fat grafting to the breast is a treatment option in conditions such as micromastia, breast ptosis, post mastectomy breast reconstruction, asymmetric breasts, congenital malformations of breast development and for treatment of complications associated with implant augmentation mammoplasty. In addition to fat grafting, the current surgical treatment for these conditions is mainly based on techniques requiring implant augmentation or reconstruction. Although the safety of saline implants has been well studied and documented, this data cannot be extrapolated for the newer generation silicone implants and other alternatives such as fat grafting need to be investigated. Also implant augmentation and reconstruction comes at the price of capsular contracture, implant deflation, infection and more future corrective surgeries. We plan to prospectively study the outcomes of fat grafting in patients with these conditions for a period of 5 years. The collected information will be entered into a database and will be prospectively collected and reviewed. Patients demographics, information obtained during the preoperative and postoperative visits along with the pertinent findings regarding the fat transfer to the breast will be collected into the database for our investigation.
Eligibility| Ages Eligible for Study: | 17 Years to 70 Years |
| Genders Eligible for Study: | Female |
| Accepts Healthy Volunteers: | Yes |
Inclusion Criteria:
- Women with the following conditions micromastia, breast ptosis, post mastectomy breast reconstruction, asymmetric breasts, congenital malformations of breast development and for treatment of complications associated with implant augmentation mammoplasty.
Exclusion Criteria:
- A volunteer who has a positive pregnancy test
- A volunteer who has had a cardiac stent placed within the last two months
- A volunteer with a known, current substance abuse
- A volunteer with a bleeding diathesis
- Untreated breast cancer
- A volunteer who smokes cigarettes
- Medical Conditions including untreated hypertension, renal disease, diabetes mellitus
Contacts and Locations| Contact: Kamran Khoobehi, MD | 504-779-5538 | |
| Contact: Alireza Sadeghi, MD | 504-273-9800 |
| United States, Louisiana | |
| Houma Outpatient Surgery Center | Recruiting |
| Metairie, Louisiana, United States, 70006 | |
| Contact: Kamran Khoobehi, MD 504-779-5538 khoobehi@aol.com | |
| Principal Investigator: Kamran Khoobehi, MD | |
| Sub-Investigator: Alireza Sadeghi, MD | |
| Medical Center of Louisiana New Orleans, LSU Health Sciences Center | Recruiting |
| New Orleans, Louisiana, United States, 70112 | |
| Contact: Kamran Khoobehi, MD FACS 504-779-5538 khoobehi@aol.com | |
| Contact: Alireza Sadeghi, MD dssadeghi@yahoo.com | |
| Principal Investigator: Kamran Khoobehi, MD | |
| Sub-Investigator: Alireza Sadeghi, MD | |
| Principal Investigator: | Kamran Khoobehi, MD | LSUHSC |
| Study Director: | Alireza Sadeghi, MD | LSUHSC |
More Information
Additional Information:
Publications:
| Responsible Party: | Kamran Khoobehi MD FACS, LSUHSC |
| ClinicalTrials.gov Identifier: | NCT00775788 History of Changes |
| Other Study ID Numbers: | 7006 |
| Study First Received: | October 15, 2008 |
| Last Updated: | November 17, 2008 |
| Health Authority: | United States: Institutional Review Board |
Keywords provided by Louisiana State University Health Sciences Center in New Orleans:
|
Fat Injection to Breast Fat Grafting to Breast |
Additional relevant MeSH terms:
|
Congenital Abnormalities |
ClinicalTrials.gov processed this record on May 23, 2013